New Orleans, LA – LSU Health New Orleans is one of 12 universities and health care entities conducting the first large-scale, multi-institutional study to help determine why African- American men are at higher risk for developing aggressive prostate cancer and dying from it. The $26.5 million RESPOND, or Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Tumor Markers, and Social Stress, study is funded by the National Cancer Institute, the National Institute on Minority Health and Health Disparities and the Prostate Cancer Foundation.
The researchers will investigate the genetic and environmental factors that could contribute to the development and course of prostate cancer in this population, including behaviors, social stressors, socioeconomic status and environment, education and life events such as discrimination.
According to the National Cancer Institute, African-American men have about a 15% chance of developing prostate cancer in their lifetimes, compared to about a 10% chance for white men, and African-American men are more likely to be diagnosed with disease that grows and spreads rapidly. More African-American men also die from it. The prostate cancer death rate of African-American men is more than two times higher than that of white men.
Article originally posted at